Clinical Advisory Board

The mission of DermOne’s independent Clinical Advisory Board is to support DermOne’s affiliated dermatology specialists in building and sustaining a culture of clinical excellence. The invited members, all renowned leaders in advanced dermatology education, clinical practice, advocacy and innovation, provide perspective and education to ensure that the clinical capabilities within the DermOne team of affiliated providers are of the highest caliber. Working in direct concert with DermOne’s Chief Medical Officer, the Clinical Advisory Board helps to ensure that a complete and accurate understanding of issues critical to the affiliated physician network’s stated mission is consistently achieved. The diverse experience and expertise of the Clinical Advisory Board reflect the breadth of DermOne affiliated provider capabilities and geographic, ethnic and gender diversity, much like the population that DermOne’s affiliated providers serve.


Website Murad-Alam-MD-201311-LBP8671

Murad Alam, MD

Dr. Murad Alam is vice chair; professor of dermatology, otolaryngology and surgery; and chief of the Cutaneous and Aesthetic Surgery division at Northwestern University Feinberg School of Medicine. He received his undergraduate and medical degrees from Yale University. Dr. Alam completed his internship in internal medicine at the University of Michigan and residency training in dermatology at Columbia University. He subsequently received fellowship training in laser and cosmetic surgery at SkinCare Physicians/Harvard Medical School in Boston, MA, and Mohs micrographic surgery at DermSurgery Associates in Houston, TX.

An author of over 150 publications, Dr. Alam is head of the surgical advisory board of JAMA Dermatology, associate editor of Lasers in Medical Science and assistant editor of Dermatologic Surgery. He is co-editor of the “Procedures in Cosmetic Dermatology” series, and overall has edited 20 books, including Evidence-Based Procedural Dermatology, Cosmetic Dermatology for Skin of Color, Requisites in Cosmetic Dermatology, Body Rejuvenation, Non-Surgical Tightening and Lifting, Treatment of Leg Veins, and Merkel Cell Carcinoma. He is co-head of the Dermatologic and Cosmetic Surgery section of the Faculty of 1000. Dr. Alam is currently secretary of the board of directors of the American Society for Dermatologic Surgery and a member of the board of directors of the Women’s Dermatologic Society; he was formerly a member of the board of directors of the American College of Mohs Surgery. He is chair of the American Academy of Dermatology’s healthcare finance committee; an adviser to the American Medical Association’s Current Procedural Terminology Committee that oversees definitions for all medical procedures in the U.S.; a member of the Nonmelanoma Skin Cancer Panel of the National Comprehensive Cancer Network that develops federally recognized guidelines for the clinical care of cancer; and a voting member on the General and Plastic Surgery Devices Panel of the Food and Drug Administration.

Dr. Alam is vice president of the Blade and Light Society, an organization of volunteer dermatologic surgeons who perform charitable mission work to treat skin cancers and train surgical dermatologists in underserved countries. Dr. Alam’s clinical practice includes the treatment of skin cancer, as well as cosmetic dermatology and laser surgery. His research is on the effectiveness, side effects and costs of different surgical treatments. Dr. Alam is director of the Northwestern University Accreditation Council for Graduate Medical Education-approved fellowship training program in procedural dermatology, and the Northwestern University American Society for Dermatologic Surgery-approved fellowship training program in cosmetic dermatologic surgery, both of which provide advanced dermatologic surgery training to a select group of board-certified dermatologists.

Website Dr. Callendar photo

Valerie Callender, MD

Dr. Valerie Callender is an internationally recognized board-certified dermatologist who is known for her sensitive and cutting-edge approach to the management of hair loss in women and the treatment of pigment disorders. Dr. Callender is a prolific contributor to the dermatologic literature and has coedited a textbook on treatment for skin of color. She has written 20 textbook chapters and more than 50 peer-reviewed articles for academic journals and is frequently invited to speak at national and international meetings. Dr. Callender has conducted and participated in over 50 research studies and clinical trials for both therapeutic and cosmetic products and is a consultant for some of the world’s leading cosmetic and consumer brands. Dr. Callender has performed leadership roles in many dermatologic organizations, including the Women’s Dermatologic Society and the Skin of Color Society – she is past president of both societies – and has recently been elected to the board of directors of the American Academy of Dermatology. She is the founder of the Callender Dermatology & Cosmetic Center, which is located in the Washington, DC, metropolitan area. Dr. Callender received her medical degree from Howard University, where she also did her residency, and currently serves as a professor of dermatology at the Howard University College of Medicine.

eichenfeld_400x560Lawrence F. Eichenfield, MD

Dr. Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego, and Professor of Pediatrics and Medicine (Dermatology), at the University of California, San Diego (UCSD), School of Medicine. He earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children’s Hospital of Philadelphia, and completed dermatology training at the Hospital of the University of Pennsylvania. He has been board certified in pediatrics, dermatology and pediatric dermatology.

Dr. Eichenfield’s clinical interests include atopic dermatitis, acne, vascular lesions (port wine stains, hemangiomas), psoriasis, neonatal dermatology, laser surgery, nevi (moles), and skin signs of systemic disease. He is Editor-in-Chief of Pediatric Dermatology and serves on the editorial boards of multiple journals and periodicals. Dr. Eichenfield has published more than 250 journal articles, chapters and abstracts, and books, and is senior editor of Neonatal & Infant Dermatology, published by Elsevier, and The Eczemas published by Summit Communications. He is Director of Rady Children’s Hospital Eczema & Inflammatory Disease Center and the Vascular Lesion & Birthmark Center.

Dr. Eichenfield was honored as a member of the Alpha Omega Alpha Medical Honor Society during medical school, as a recipient of the Benjamin Ritter Award at Children’s Hospital of Philadelphia, and has received excellence in teaching awards from UCSD Pediatrics, UCSD Dermatology, and Rady Children’s Hospital, San Diego. He has been named one of the “Best Doctors in America” since 1994.

Dr. Eichenfield is past president of the Society for Pediatric Dermatology, has served on the Board of the American Academy of Dermatology, and served as Chair for the 69th Annual Meeting of the American Academy of Dermatology. Dr. Eichenfield is a founding board member and President of the American Acne & Rosacea Society, and is Co-Chair of the Pediatric Dermatology Research Alliance (PeDRA), a collaborative research network.

Dr. Eichenfield enjoys running, skiing, reading and (bad) golf.

Website Munavalli photo

Gilly Munavalli, MD

Dr. Gilly Munavalli is medical director and founder of Dermatology, Laser & Vein Specialists of the Carolinas in Charlotte, NC. He trained in dermatology at Emory University and completed dermatologic surgery fellowships in Mohs micrographic surgery and laser surgery at the University of California, San Francisco. He also completed a phlebology and advanced laser surgery fellowship at the Maryland Dermatology Laser, Skin and Vein Institute, and Johns Hopkins University. He received his Bachelor of Science from the University of North Carolina at Chapel Hill, Master of Health Science from the Johns Hopkins University Bloomberg School of Public Health, doctor of medicine from the Morehouse School of Medicine in Atlanta, GA, and internship training at the Mayo Clinic. Dr. Munavalli received his board certification in dermatology in 2002.

Dr. Munavalli is an author or a co-author of over 50 publications and book chapters. His medical memberships include being a board-certified member of the American Academy of Dermatology and a member and fellow of the American College of Mohs Micrographic and Cutaneous Oncology, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and American College of Phlebology. His current affiliations include assistant professor of dermatology at the Wake Forest University Department of Dermatology and clinical assistant professor in the Department of Medicine at the University of North Carolina School of Medicine, Carolinas Medical Center.

Website Dr. Ozog photo

David M. Ozog, MD

DAVID M OZOG, currently serves as Chair, Department of Dermatology and holds the C.S. Livingood Chair in Dermatology, at Henry Ford Hospital, Detroit, Michigan. He is also an active Mohs surgeon and Director of Cosmetic Dermatology.  He received his Undergraduate degree from the University of Michigan where he was a James B. Angell 4.0 GPA Scholar, completed post baccalaureate work at Bryn Mawr in Philadelphia and his medical degree from University of Rochester Medical School, Rochester, New York where he was awarded AOA honors society.  He completed his dermatology residency at Henry Ford Hospital in Detroit where he served as Chief Resident.  His Mohs, Cosmetic and Procedural fellowship was with Dr Ron Moy at UCLA Medical Center and Moy-Fincher Medical Group in Beverly Hills, CA.  He has published more than 70 articles and book chapters, and has given hundreds of lectures nationally and internationally in various facets of procedural dermatology. His textbook, co-edited with Joel Cohen, “Botulinum Toxins: Cosmetic and Clinical Applications” was published in 2017.

Dr Ozog has directed sessions at the American Academy of Dermatology annual meeting for several years, was a member of the AAD coding committee, and is a currently serving on the AAD Scientific Assembly Committee for a six year term.  He is scheduled to Chair both Summer and Annual AAD meetings.  He is also an editorial board member of JAMA Dermatology and an assistant editor of Dermatologic Surgery.  His active research interests include cutaneous oncology, scarring prevention and treatment, botulinum toxins, as well as laser delivery for cosmetic and malignant conditions. He has trained more than 70 residents in dermatological surgery and was chosen by the residents as “Teacher of the Year”.    Dr Ozog has taught hands on workshops nationally for the American Society for Dermatological Surgery and is co-director of the cadaver lab at Henry Ford.  He enjoys biking and spending time with his wife Dawnmarie and their three children.

Victoria Werth

Victoria Werth, MD

Dr. Victoria Werth is a Professor of Dermatology and Medicine at the University of Pennsylvania School of Medicine and past-president of the Rheumatologic Dermatology Society. She is co-founder of the Medical Dermatology Society and a recipient of their lifetime achievement award. She has a longstanding interest in clinical and translational research of cutaneous autoimmune diseases, including autoimmune blistering diseases, lupus erythematosus, and dermatomyositis, with a focus to improving the treatment and outcomes of autoimmune dermatologic diseases. Clinically, Dr. Werth sees mainly referred patients with autoimmune skin disease, and she conducts basic, translational, and clinical research in these conditions.

Dr. Werth helped develop and validate the Cutaneous Lupus Area and Severity Index (CLASI), which is a validated instrument to measure cutaneous activity and damage in lupus, and a second index for dermatomyositis, the CDASI. Currently, she leads a multicenter collaborative, web-based database to collect prospective information on patients with skin and systemic manifestations of lupus erythematosus. This represents the first systematic epidemiologic study of cutaneous lupus erythematosus (CLE) in the United States, with a goal to assess disease severity, quality of life, and response to treatment, as well as complete validation studies of the CLASI. Additionally, Dr. Werth leads several ongoing clinical studies investigating novel therapeutics for cutaneous lupus erythematosus, dermatomyositis, and autoimmune blistering disease. Her laboratory investigations include studies of potential biomarkers in cutaneous lupus, pathogenesis of cutaneous lupus, and ultraviolet light effects on skin. Recent clinical studies have examined mechanistic effects of therapeutics in CLE, as well as subset-specific expression of interferon signatures.

Dr. Werth works closely with the Lupus Foundation of America, the Lupus Research Institute/Alliance for Lupus Research, and the International Myositis Assessment & Clinical Studies Group (IMACS). Her work has been funded by NIH, the VA, as well as the Lupus Foundation of America, Lupus Research Institute, and the Alliance for Lupus Research. She has served on the medical advisory board for the Lupus Foundation of America, the Myositis Foundation, and the International Pemphigus and Pemphigoid Foundation (IPPF). She also works closely with the Lupus Research Alliance.